# A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Acute Vulvovaginal Candidiasis

> **NCT04956419** · PHASE3 · UNKNOWN · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 322 (actual)

## Conditions studied

- Acute Vulvovaginal Candidiasis

## Interventions

- **DRUG:** SHR8008 capsule
- **DRUG:** Fluconazole capsule

## Key facts

- **NCT ID:** NCT04956419
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-24
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 322 (ACTUAL)
- **Last updated:** 2021-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04956419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04956419, "A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Acute Vulvovaginal Candidiasis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04956419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*